# Testing Potential Synergistic Effects of Albuterol and Caffeine on Metabolic Rate

> **NCT02135965** · EARLY_PHASE1 · COMPLETED · sponsor: **Pennington Biomedical Research Center** · enrollment: 8 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** 2mg of Albuterol
- **DRUG:** 4mg of Albuterol
- **DRUG:** 100mg of Caffeine
- **DRUG:** 200mg of Caffeine
- **DRUG:** Albuterol 2mg & Caffeine 100mg
- **DRUG:** Albuterol 2mg and Caffeine 200mg
- **DRUG:** Albuterol 4mg and Caffeine 100mg
- **DRUG:** Albuterol 4mg and Caffeine 200mg

## Key facts

- **NCT ID:** NCT02135965
- **Lead sponsor:** Pennington Biomedical Research Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2015-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02135965

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02135965, "Testing Potential Synergistic Effects of Albuterol and Caffeine on Metabolic Rate". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02135965. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*